BIOGEN INC. - COMMON STOCK

Biogen and Ionis Announce Topline Phase 1/2 Study Results of Investigational Drug in Amyotrophic Lateral Sclerosis

16 مايو 2024 07:30:14 بحسب Nasdaq GlobeNewswire

Eisai Initiates Rolling Biologics License Application to US FDA for LEQEMBI® (lecanemab-irmb) for Subcutaneous Maintenance Dosing for the Treatment of Early Alzheimer’s Disease Under the Fast Track Status

14 مايو 2024 19:33:37 بحسب Nasdaq GlobeNewswire

Biogen Reports Progress on Corporate Responsibility Priorities

02 مايو 2024 07:30:00 بحسب Nasdaq GlobeNewswire

Biogen Receives Positive CHMP Opinion for TOFIDENCE™ (tocilizumab), a Biosimilar Referencing ROACTEMRA®

25 أبريل 2024 16:05:00 بحسب Nasdaq GlobeNewswire

NetDania - New 12 months Low: BIOGEN INC. - COMMON STOCK

19 أبريل 2024 09:50:39 بحسب NetDania Notify

NetDania - New 12 months Low: BIOGEN INC. - COMMON STOCK

18 أبريل 2024 09:45:07 بحسب NetDania Notify

NetDania - New 12 months Low: BIOGEN INC. - COMMON STOCK

17 أبريل 2024 09:50:10 بحسب NetDania Notify

NetDania - New 12 months Low: BIOGEN INC. - COMMON STOCK

16 أبريل 2024 09:45:06 بحسب NetDania Notify

NetDania - New 12 months Low: BIOGEN INC. - COMMON STOCK

15 أبريل 2024 09:45:35 بحسب NetDania Notify

NetDania - New 12 months Low: BIOGEN INC. - COMMON STOCK

12 أبريل 2024 12:00:50 بحسب NetDania Notify

NetDania - New 12 months Low: BIOGEN INC. - COMMON STOCK

10 أبريل 2024 09:45:08 بحسب NetDania Notify

NetDania - New 12 months Low: BIOGEN INC. - COMMON STOCK

05 أبريل 2024 09:45:10 بحسب NetDania Notify

NetDania - New 12 months Low: BIOGEN INC. - COMMON STOCK

04 أبريل 2024 09:53:33 بحسب NetDania Notify

NetDania - New 12 months Low: BIOGEN INC. - COMMON STOCK

03 أبريل 2024 09:55:31 بحسب NetDania Notify

NetDania - New 12 months Low: BIOGEN INC. - COMMON STOCK

02 أبريل 2024 09:45:41 بحسب NetDania Notify

NetDania - New 12 months Low: BIOGEN INC. - COMMON STOCK

01 أبريل 2024 10:34:07 بحسب NetDania Notify

NetDania - New 12 months Low: BIOGEN INC. - COMMON STOCK

26 مارس 2024 09:50:02 بحسب NetDania Notify

New Biomarker Data Add Further Evidence Supporting the Potential Benefit of SPINRAZA® (nusinersen) in Infants and Toddlers with Unmet Clinical Needs after Gene Therapy

06 مارس 2024 07:30:51 بحسب Nasdaq GlobeNewswire

Biogen Highlights New Data at the International Conference on Alzheimer’s and Parkinson’s Diseases (AD/PD™) 2024 Annual Meeting

04 مارس 2024 16:15:57 بحسب Nasdaq GlobeNewswire

NetDania - New 12 months Low: BIOGEN INC. - COMMON STOCK

01 مارس 2024 09:47:17 بحسب NetDania Notify